TGFB1 and liver cancer: In this study, we evulated the effects of ECH on the progression of liver cancer cells, and found that ECH exerted an anti-tumor activity via the miR-503-3p/TGF-β1/Smad aixs in liver cancer, and provides a safe and effective anti-tumor agent for liver cancer.